Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
KESIMPTA Inj Lös 20 mg/0.4ml Fertpen 0.4 ml
Drug
Kesimpta, Injektionslösung in Fertigpen
Multiple Sklerose
01.99.0. – various
HAM – Human medicine
INLFP – Solution for injection in pre-filled pen
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
2/1/2021
1/31/2026
Dosage strength
Kesimpta, Injektionslösung in Fertigpen
Multiple Sklerose
01
Z – approved
Package
7680677580017
In trade from / since 2/1/2021
A/R – Authorised / referenced
1 piece(s)
001
Z – approved
Declaration
Component
20 mg ofatumumabum
argininum
natrii acetas trihydricus
natrii chloridum
polysorbatum 80
dinatrii edetas
acidum hydrochloridum 25 per centum
aqua ad iniectabile
0.92 mg natrium
natrii acetas trihydricus
natrii chloridum
polysorbatum 80
dinatrii edetas
acidum hydrochloridum 25 per centum
aqua ad iniectabile
0.92 mg natrium
Spezialitätenliste***
SL
-
-
1255.55
None
Yes
10%
No
Authorisation holder
7601001300477
Novartis Pharma Schweiz AG
6343 Risch (ZG)
6343 Risch (ZG)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.